Related Experiment Videos
Preparation and characterization of heparin-loaded polymeric microparticles
Y Y Jiao1, N Ubrich, V Hoffart
1Laboratoire de Pharmacie Galénique et Biopharmacie, Faculté de Pharmacie, 5, rue Albert Lebrun, B.P. 403, 54001 Nancy, France.
Drug Development and Industrial Pharmacy
|October 16, 2002
Summary
Biodegradable and non-biodegradable polymers were used to create heparin microparticles. Different polymer blends and excipients influenced particle size, encapsulation, and release kinetics, maintaining heparin
Area of Science:
- Materials Science
- Polymer Chemistry
- Pharmaceutical Technology
Background:
- Heparin delivery systems are crucial for various therapeutic applications.
- Developing microparticle formulations requires careful selection of polymers and excipients to control drug release.
- Biodegradable and non-biodegradable polymers offer distinct properties for drug encapsulation.
Purpose of the Study:
- To investigate the preparation of heparin-loaded microparticles using biodegradable and non-biodegradable polymers.
- To evaluate the impact of different polymers (PCL, PLGA, Eudragit RS/RL) and excipients (gelatin, NaCl) on microparticle characteristics.
- To assess the in vitro release kinetics and biological activity of encapsulated heparin.
Main Methods:
- Water-in-oil-in-water emulsification and evaporation technique for microparticle preparation.
- Analysis of particle size, morphology, and drug entrapment efficiency.
- In vitro drug release studies and anti-Xa activity assay to confirm heparin's biological integrity.
Main Results:
- Microparticle diameters ranged from 80-130 microns, influenced by gelatin A addition.
- Eudragit RS/RL microparticles showed higher entrapment but lower 24-hour release compared to PCL/PLGA.
- Polymer blends modified entrapment and release kinetics; gelatin A increased entrapment but caused an initial burst release.
- Released heparin retained its anti-Xa biological activity, confirming no degradation during formulation.
Conclusions:
- Heparin microparticles can be successfully prepared using various biodegradable and non-biodegradable polymers.
- Polymer choice and excipients significantly modulate microparticle properties and drug release profiles.
- Formulated heparin maintains its therapeutic efficacy, indicating a promising approach for controlled heparin delivery.